InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
3
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+6.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by LEE KENNETH B JR. Officer active across 3 companies, notably Eyenovia, INC.. Cumulatively, 12 disclosures have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €38k. History available since 11 June 2021. The latest transaction was disclosed on 13 June 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
16,745 shares0Common StockSEC:0001127602-23-018791:0
15,000 shares@ US$1.7122.4% of flowCommon StockSEC:0001127602-23-003163:0
22,222 shares0Common Stock, par value $.0001SEC:0001415889-22-006807:0
12,866 shares0Common StockSEC:0001127602-22-017144:0
10,000 shares@ US$2.2054.1% of flowCommon Stock, par value $.0001SEC:0001415889-22-005467:0
Ideal exit: 13 Feb 2023 (T+270)
6,963 shares0Common Stock, par value $.0001SEC:0001415889-21-005357
6,963 shares0Common Stock, par value $.0001SEC:0001415889-21-005357:0
15,000 shares@ US$3.220.0025% mcap50.0% of flowCommon StockSEC:0001127602-21-025331:0
15,000 shares@ US$3.2238.8% of flowCommon StockSEC:0001127602-21-025331
2,000 shares@ US$5.3823.0% of flowCommon Stock, par value $.0001SEC:0001638599-21-000551
Ideal exit: 8 Mar 2022 (T+270)
2,000 shares@ US$5.3823.0% of flowCommon Stock, par value $.0001SEC:0001638599-21-000551:0
Ideal exit: 8 Mar 2022 (T+270)
72,966 sharesCommon SharesSEC:0001104659-16-095182:0
12 of 12 declarations
About LEE KENNETH B JR
Kenneth B Jr Lee is a director at Eyenovia, INC. and is also associated with Biocryst Pharmaceuticals INC.
